TITLE

The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trial

AUTHOR(S)
Blomster, Juuso I.; Woodward, Mark; Zoungas, Sophia; Hillis, Graham S.; Harrap, Stephen; Neal, Bruce; Poulter, Neil; Mancia, Giuseppe; Chalmers, John; Huxley, Rachel
PUB. DATE
January 2016
SOURCE
BMJ Open;2016, Vol. 6 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
112400083

 

Related Articles

  • Effects of intensive glucose lowering in type 2 diabetic patients.  // Australian Journal of Pharmacy;Mar2009, Vol. 90 Issue 1066, p76 

    The article presents an overview of the studies that examined the effects of intensive glucose lowering in type 2 diabetes patients. It notes that the results of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial has indicated the increasing rate of mortality while posing major...

  • Cardiolgy today Trial Scorecards.  // Cardiology Today;Jul2008, Vol. 11 Issue 7, p10 

    A list of trial scorecards in cardiology is presented including the Antiarrhythmics After Ablation of Atrial Fibrillation (5A Study), the Action to Control Cardiovascular Risk in Diabetes (ACCORD), and Action in Diabetes and Vascualr Disease: Preterax and Diamicron Modified release Controlled...

  • COMMENTARY. Montori, Victor M.; Malaga, German // Evidence Based Medicine;Dec2008, Vol. 13 Issue 6, p168 

    The article presents a commentary on a study on the intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. The author provides his views on the study's design called ADVANCE, Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release...

  • Neuropathy: The Crystal Ball for Cardiovascular Disease? Vinik, Aaron I.; Maser, Raelene E.; Ziegler, Dan // Diabetes Care;Jul2010, Vol. 33 Issue 7, p1688 

    The authors comment on three studies which aimed to address the question of more intensive therapy and reduction in cardiovascular complications for people with type 2 diabetes. These studies include the Action to Control Cardiovascular Risk in Diabetes (ACCORD), the Action in Diabetes and...

  • A Summary of the ADVANCE Trial. Heller, Simon R. // Diabetes Care;Nov2009 Supplement, Vol. 32, pS357 

    The article provides information on the Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation (ADVANCE) trial which aims to find out whether intensifying glucose control to achieve a glycated hemoglobin (A1C) level of <6.5% would give additional benefit in...

  • Routine Administration of Perindopril-Indapamide Reduces the Risk of Kidney Events Associated within Diabetes. Ninomiya, Toshiharu; Perkovic, Vlado // AUANews;Dec2009, Vol. 14 Issue 12, p3 

    The article discusses the Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation (ADVANCE) trial on the impact of routine administration of a fixed combination of the angiotensin-converting enzyme ( (ACE) inhibitor perindopril and diuretic indapamide on the risk...

  • Meeting Coverage. Intensive glycemic management leads to higher mortality in T2DM patients. Kaufman, Michele B. // Formulary;Apr2011, Vol. 46 Issue 4, p149 

    Information about the results from two clinical trials discussed at the 58th annual advanced postgraduate course, sponsored by the American Diabetes Association (ADA), is presented. Topics include an overview of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, the Action in...

  • Intensive glucose control did not prevent important complications in type 2 diabetes. Patel, A. // Evidence Based Medicine;Dec2008, Vol. 13 Issue 6, p168 

    Design: randomised controlled trial (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation [ADVANCE]). Allocation concealment: concealed. Blinding: blinded (outcome adjudication committee). Setting: 215 centres in 20 countries in Asia,...

  • Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes. Leeuw, Joep; Visseren, Frank; Woodward, Mark; Graaf, Yolanda; Grobbee, Diederick; Harrap, Stephen; Heller, Simon; Mancia, Giuseppe; Marre, Michel; Poulter, Neil; Zoungas, Sophia; Chalmers, John // Diabetologia;Dec2016, Vol. 59 Issue 12, p2603 

    Aims/hypothesis: Intensive glucose control reduces the risk of vascular complications while increasing the risk of severe hypoglycaemia at a group level. We sought to estimate individual beneficial and adverse effects of intensive glucose control in patients with type 2 diabetes. Methods: We...

  • Risk - Complications and Comorbidities.  // Current Medical Literature: Diabetes;2010, Vol. 27 Issue 3, p91 

    The article presents expert commentaries on various research studies on the risk of complications and comorbidities of patients with diabetes. A study has found that aggressive treatment for hyperglycemia in patients receiving total parenteral nutrition (TPN) may improve clinical outcomes....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics